Anrufen Wegbeschreibung Website Service kontaktieren

DECHEMA Wissenschaft und Industrie im Dialog. Die DECHEMA ist das kompetente Netzwerk für chemische Technik

Die DECHEMA Gesellschaft für Chemische Technik und Biotechnologie e.V. führt Fachleute unterschiedlicher Disziplinen, Institutionen und Generationen zusammen, um den wissenschaftlichen Austausch in chemischer Technik, Verfahrenstechnik und Biotechnologie zu fördern. Wir suchen nach neuen technologischen Trends, bewerten diese und begleiten die Umsetzung von Forschungsergebnissen in technische Anwendungen. Die DECHEMA ist Kern eines interdisziplinären Netzwerks von themenbezogenen Gremien und organisiert Veranstaltungen und Weiterbildung für alle, die an einem Fachthema interessiert sind. Mehr als 5.800 Personen und Organisationen gehören der DECHEMA als Mitglieder an. In der Fachgemeinschaft Biotechnologie und in ProcessNet, der gemeinsamen Plattform für chemische Technik, begegnen sich Naturwissenschaftler, Ingenieure, Studierende, Firmen und Institutionen und tauschen sich aus. Darüberhinaus betreuen wir Förderbereiche sowie nationale und europäische Forschungsverbünde. Als Mitglied der AiF organisieren wir Projekte der Industriellen Gemeinschaftsforschung. Gemeinsam mit der DECHEMA Ausstellungs-GmbH sind wir Veranstalter der ACHEMA, des Weltforums der Prozessindustrie. Mit dem DECHEMA-Forschungsinstitut, das Forschung für nachhaltige Technologien in den Bereichen Biotechnologie, Werkstoffe und Chemische Technik betreibt, arbeiten wir eng zusammen.

How can industrial biotechnology move from promising science to commercial success?Our new open-access paper, “From cell...
15/10/2026

How can industrial biotechnology move from promising science to commercial success?

Our new open-access paper, “From cells to sales: Advancing the commercialization of industrial biotech innovations” explores this question drawing on interviews with experienced biotech investors and founders, as well as real-world case studies.

The paper identifies six key areas that can determine whether an industrial biotech venture successfully reaches the market:
· Technology development
· Product and market selection
· Cooperation and partnerships
· Team structure and competences
· Intellectual property management
· Financing strategy

One of the study’s key findings is the importance of a market-oriented development logic: “market first, technology second.” Instead of advancing an invention in isolation, founders and research institutions should assess market requirements at an early stage and use them to guide technology and process development.

We thank all interview partners for sharing their experience and perspectives on the opportunities and challenges on the long journey from cells to sales:

Joško Bobanović, Sofinnova Partners
Michael Brandkamp, European Circular Bioeconomy Fund (ECBF)
Jens Busse, Evonik Venture Capital
Hugo Delissen, Brightlands Chemelot Campus
Christina Doumitrachko, DeepTech & Climate Fonds (DTCF)
Luisa Gronenberg, Insempra GmbH
Susanne Gürich, HIGHEST Innovations- und Gründungszentrum TU Darmstadt
Nicolas Krink, Federal Agency for Disruptive Innovation SPRIND
Georg Lentzen, b.value
Matthew Lipscomb, DMC Biotechnologies, Inc.
Rob van der Meij, Capricorn Partners
Nik Raupp, High-Tech Gründerfonds (HTGF)

Read the open-access paper:
https://doi.org/10.1016/j.nbt.2026.09.006

Assessing the potential of a new processes? Explore the expertise of DECHEMA Analysis + Consulting: https://ac.dechema.de/en/By+DECHEMA.html

What happens when organoid technology meets artificial intelligence in precision oncology?At 3D Cell Culture 2027, Prof....
13/10/2026

What happens when organoid technology meets artificial intelligence in precision oncology?

At 3D Cell Culture 2027, Prof. Dr. Marianna Kruithof-de Julio from the Department of Urology at Inselspital Bern will explore this intersection in her keynote:

“ORION flagship: From organoids to algorithms – An AI-driven autonomous microfactory for precision oncology”

Her talk will highlight the ORION flagship and its approach to combining organoid models with AI-driven technologies to advance precision oncology.

3D Cell Culture 2027
16–18 March 2027 | Freiburg, Germany

The conference brings together scientists, clinicians, and industry experts to explore how next-generation 3D models—from organoids and cellular aggregates to microphysiological systems (MPS)—can advance functional precision medicine and help translate research into clinical impact.

Want to contribute your own research? The Call for Papers is open until 28 October 2026.

Find out more, submit your paper and register:
https://dechema.de/en/3DCC2027.html

How can vascularized organoid models help bridge the gap between research and drug development?At 3D Cell Culture 2027, ...
08/10/2026

How can vascularized organoid models help bridge the gap between research and drug development?

At 3D Cell Culture 2027, Dr. Reiner Wimmer from the Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., will address this question in his keynote:

“Vascularized organoid models for drug development”

His talk will explore the potential of vascularized organoid models in drug development and how advanced 3D models can contribute to more physiologically relevant research.

3D Cell Culture 2027
16–18 March 2027 | Freiburg, Germany

The conference brings together scientists, clinicians, and industry experts to explore how next-generation 3D models—from organoids and cellular aggregates to microphysiological systems (MPS)—can advance functional precision medicine and help translate research into clinical impact.

Want to contribute your own research? The Call for Papers is open until 28 October 2026.
Find out more, submit your paper and register:
https://dechema.de/en/3DCC2027.html

How can we capture the dynamics of organoids in action?At 3D Cell Culture 2027, Prof. Dr. Ruslan Dmitriev from the Depar...
06/10/2026

How can we capture the dynamics of organoids in action?

At 3D Cell Culture 2027, Prof. Dr. Ruslan Dmitriev from the Department of Human Structure and Repair at Ghent University will share new perspectives on this question in his keynote:

“New tools for dynamic imaging of organoids”

His talk will highlight innovative approaches for visualizing and studying organoids dynamically, opening up new possibilities for understanding complex biological processes in 3D models.

3D Cell Culture 2027
16–18 March 2027 | Freiburg, Germany

The conference brings together scientists, clinicians, and industry experts to explore how next-generation 3D models—from organoids and cellular aggregates to microphysiological systems (MPS)—can advance functional precision medicine and help translate research into clinical impact.

Want to contribute your own research? The Call for Papers is open until 28 October 2026.

Find out more, submit your paper and register:
https://dechema.de/en/3DCC2027.html

39th Irsee Natural Product Symposium – Call for Posters is open.Biologically active natural products play a vital role i...
05/10/2026

39th Irsee Natural Product Symposium – Call for Posters is open.
Biologically active natural products play a vital role in basic research as well as in pharmaceutical and agrochemical R&D.

For more than three decades, the Irsee Natural Product Symposium has brought together scientists from different disciplines to discuss current developments, exchange ideas and strengthen connections within the natural products community.

A special focus is placed on young scientists: Young researcher sessions and poster presentations offer an excellent opportunity to showcase your research, exchange ideas with experts and peers, and build valuable connections.

The Organising Committee kindly invites you to actively participate and submit your poster!
📅 Poster submission deadline: 30 October 2026

Join us for the 39th Irsee Natural Product Symposium and become part of the exchange shaping the future of natural products research.

Find out more: https://dechema.de/en/Irsee2027

Dr. rer. nat. Hufsah Ashraf, Universitätsklinikum Düsseldorf, erhält den Dissertationspreis Bioinformatik 2026 der gemei...
02/10/2026

Dr. rer. nat. Hufsah Ashraf, Universitätsklinikum Düsseldorf, erhält den Dissertationspreis Bioinformatik 2026 der gemeinsamen Fachgruppe Bioinformatik (FaBI) von DECHEMA, GBM, GDCh, GI, GMDS und VAAM.

In ihrer Dissertation entwickelte Frau Ashraf computergestützte Ansätze zur Erkennung und Analyse wiederkehrender genomischer Variationen in menschlichen Populationen. Dazu griff sie die Idee auf, genetische Variationen mithilfe von Pangenomgraphen darzustellen, die sich besonders gut für die Untersuchung komplexer Variationsformen eignen.

Mehr erfahren: https://dechema.de/fabi2026.html

Meet our Keynote Speaker at 3D Cell Culture 2027: Dr. Meritxell HuchWe are delighted to welcome Dr. Meritxell Huch, MPI ...
01/10/2026

Meet our Keynote Speaker at 3D Cell Culture 2027: Dr. Meritxell Huch

We are delighted to welcome Dr. Meritxell Huch, MPI of Molecular Cell Biology and Genetics and Honorary Professor for Stem Cell Research and Tissue Regeneration at TU Dresden, as a keynote speaker at 3D Cell Culture 2027.

In her keynote,
“Tissue-derived organoids: where we stand and where we go”,
she will explore the current state of tissue-derived organoid research and look ahead to where the field is heading.

📍 3D Cell Culture 2027
📅 16–18 March 2027 | Freiburg, Germany

The conference brings together scientists, clinicians, and industry experts to explore how next-generation 3D models—from organoids and cellular aggregates to microphysiological systems (MPS)—can advance functional precision medicine and help translate research into clinical impact.

Want to contribute your own research? The Call for Papers is open until 28 October 2026.

Find out more, submit your paper and register:
https://dechema.de/en/3DCC2027.html

The Call for Papers is open – submit your paper by 28 October 2026 and be part of 3D Cell Culture 2027!How do we turn so...
29/09/2026

The Call for Papers is open – submit your paper by 28 October 2026 and be part of 3D Cell Culture 2027!

How do we turn sophisticated 3D models into real clinical impact? The 3D Cell Culture 2027 (16–18 March 2027, Freiburg) brings together scientists, clinicians, and industry leaders to accelerate functional precision medicine. We will spotlight how next-generation models—organoids, cellular aggregates, and microphysiological systems (MPS)—can guide therapeutic decisions and translate mechanistic insight into better patient outcomes.

Expect a single-track format for deep, focused discussion with international experts; dynamic sessions including keynotes, pitch presentations, and a lively poster party.

Further, an extensive industry exhibition with hands-on workshops by companies will showcase enabling technologies.

Find out more about online registration and exhibition: https://dechema.de/en/3DCC2027.html: https://dechema.de/en/3DCC2027.html

From 15–17 September, the DECHEMA FORUM brought science and industry together in Frankfurt under the theme “Defossilizin...
23/09/2026

From 15–17 September, the DECHEMA FORUM brought science and industry together in Frankfurt under the theme “Defossilizing the Process Industry – Creating Competitive Solutions.” Three days of dialogue, ideas and inspiration.

A particular highlight was the series of plenary lectures, which approached the transformation of the process industry from complementary perspectives. Andrea Ramírez Ramírez opened the forum with “Reconfiguring Existing Industrial Clusters Beyond Fossil Fuels: The Challenge and Promise of System Transformation”, putting the systemic transformation of established industrial structures at the center of the discussion.

On the second day, Eva Wilke explored the potential of biotechnology with the question “Biotechnology: The Key to Revolutionizing the Chemical Industry?” The third plenary lecture was delivered by Martin Keller, who spoke on “Innovation: The Key to Future Competitiveness”.

Another highlight was the DECHEMA Innovation Award 2026, featuring KYOOBE TECH GmbH in a session chaired by Wolfram Stichert.

But DECHEMA FORUM was about much more than lectures. Across 15 interactive workshops, participants had the opportunity to exchange ideas and actively discuss topics ranging from digitalization, bioeconomy and membrane separation to CO₂ direct air capture, research data, synthetic fuels and skills for the biochemical transformation.

It was also great to see the strong focus on the next generation of scientists and engineers. The programme included the ChemPlant Competition: Final Science Pitches, organised by kjVI by VDI, the Hochschullehrernachwuchspreis (Young University Teacher Award), providing a platform for emerging talent, as well as the Foundation of the DECHEMA Young Group on energy, chemistry and climate, highlighting the important intersection of energy, chemistry and climate and strengthening the involvement of the next generation in shaping the transformation ahead.

The three days once again demonstrated the value of bringing science and industry into dialogue: connecting technological innovation with systemic thinking, creating space for interdisciplinary exchange and giving emerging talent a platform to contribute their ideas.

Thank you to all speakers, session chairs, workshop organizers, participants and partners who made DECHEMA FORUM 2026 such a vibrant meeting place for the process industry’s transformation.

Drei intensive Tage DECHEMA FORUM liegen hinter uns – heute geht das DECHEMA FORUM 2026 zu Ende!Ein besonderes Highlight...
17/09/2026

Drei intensive Tage DECHEMA FORUM liegen hinter uns – heute geht das DECHEMA FORUM 2026 zu Ende!

Ein besonderes Highlight war gestern die erstmalige Verleihung des DECHEMA Innovationspreises. 🏆 Ausgezeichnet wurde die KyooBe Tech GmbH für ihr „Innovatives Inaktivierungsverfahren zur effizienten und schonenden Herstellung von Impfstoffen“ mit den Wissenschaftler:innen Lena Schober, KyooBe Tech GmbH und Prof Sebastian Ulbert, Fraunhofer Institute for Cell Therapy and Immunology (IZI) & Universitätsprofessor für Translationale Infektionsimmunologie Medizinische Fakultät, Universität Leipzig.

Mit ihrer eFIT-Technologie setzt KyooBe auf niederenergetische Elektronenstrahlung, um Pathogene schnell und chemikalienfrei zu inaktivieren. Die Jury würdigte insbesondere die Verbindung aus wissenschaftlicher und technischer Innovation, deutlichem Zeitgewinn und interdisziplinärer Teamleistung.

Herzlichen Glückwunsch an das gesamte Team von KyooBe Tech – und vielen Dank an alle, die das DECHEMA FORUM 2026 in Frankfurt mitgestaltet haben!

Adresse

Theodor-Heuss-Allee 25
Frankfurt
60486

Öffnungszeiten

Montag 09:00 - 17:00
Dienstag 09:00 - 17:00
Mittwoch 09:00 - 17:00
Donnerstag 09:00 - 17:00
Freitag 09:00 - 17:00

Telefon

+49 69 75640

Benachrichtigungen

Erfahren Sie als Erste/r von Neuigkeiten und Aktionen: Wir schicken Ihnen eine E-Mail, wenn DECHEMA etwas veröffentlicht. Ihre E-Mail-Adresse wird für keinen anderen Zweck verwendet, und Sie können sich jederzeit abmelden.

Service Kontaktieren

Nachricht an DECHEMA senden:

Verknüpfungen

Teilen